Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has entered a collaboration with Touchlight, a biotechnology company pioneering enzymatic DNA production, through which Lonza will have the ability to integrate an additional, differentiated source of DNA in its end-to-end offering to customers developing messenger RNA (mRNA) therapeutics and vaccines, while Touchlight can widen the channels through which customers can gain access to its novel doggybone DNA (d...